December, 2025
December 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25
Dec 19, 2025, 10:51

Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25

Sarah Elkourashy, Consultant in Clinical Hematology and BMT at Hamad Medical Corporation, Assistant professor of clinical medicine at Weill Cornell Medicine-Qatar, shared on LinkedIn:

”Happy to be part of ASH Conference 2025 – ASH2025

It was a pleasure reconnecting with former colleagues and engaging with peers from across the hematology community.

The meeting offered valuable insights into the latest advances in hematology and meaningful discussions on how to further enhance the care of patients with hematological disorders.

Thankful for the rich scientific exchange and collaborative environment.

Delighted to present our poster there Shehab Mohamed, Abdulrahman Al-Mashdali

Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25

Abstracts accepted:

1.Real-world descriptive analysis of the use of bispecific t cell engagers (BiTEs) in the treatment of hematological malignancies in Qatar: A state-wide retrospective study cohort

Read the full article in Blood.

Authors: Rawan Dawoud, Farah Jibril, Maria Benkhadra, Sahar Nasser, Amaal Gulied, Anas Hamad, Honar Charif, Mohamed Yassin, Ruba Yasin Taha, Safaa Alazawi, Hesham Elsabah, Deena Mudawi, Sarah Elkourashy, Shereen Elazzazy

2.Caplacizumab as a pre-emptive therapy in thrombotic thrombocytopenic purpura: A proactive strategy to reduce morbidity

Read the full article in Blood.

Authors: Maria Benkhadra, Abdulrahman Al-Mashdali, Sarah Elkourashy, Anas Hamad, Shehab Mohamed, Halima El Omri, Honar Cherif

Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25

3.Caplacizumab for pediatric immune thrombotic thrombocytopenic purpura: A scoping review of current evidence

Read the full article in Blood.

Authors: Abdulrahman Al-Mashdali, Samah M Salihb, Priyadarshini Vatsyayanc, Deena Mudawi, Sarah Elkourashy, Dina Soliman, Honar Charif, Shehab Mohamed

Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25

All from ASH25 featured in Hemostasis Today.